INSIGHTS ON CLINICAL TRIAL DESIGN
-
Inspection Facilitation Without Local MAH Presence
Local expertise and centralized oversight ensured compliant, well‑coordinated inspections across countries, reducing operational risk and client burden while maintaining consistent authority engagement.
-
Beyond The Database: Reaching Real Patients In Real Communities
There’s fatigue around “database-only” recruitment tactics. This presentation spotlights how patient-centric, local engagement are outperforming traditional pipelines.
-
Meeting Your Clinical Trial Enrollment Target Without Delays
Bridge the enrollment gap by blending site-based tactics with global direct-to-patient outreach. Use digital screening and EMR intelligence to ensure faster, more predictable paths to randomization.
-
Faster Starts, Stronger Finish: Operational Excellence In NSCLC
In NSCLC trials, data‑driven site selection, streamlined protocols, efficient screening strategies, and proactive engagement can accelerate enrollment and improve trial efficiency across regions.
-
Developing Community-Based And Trial-Naïve Sites: The Real ROI9/9/2025
Trial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment.
-
Patient Trust And Engagement In The Age Of Decentralized Trials4/10/2025
To truly maximize enrollment in decentralized models, sponsors must invest in human connection to build the trust needed to move patients from awareness to active participation.
-
Vendor Selection Bias: Why Structured Decisions Often Fail12/22/2025
Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
-
Reducing The Travel Burden For Patients - The Benefits Of Mobile Vision Clinics3/11/2025
Travel to trial sites can be a major hurdle for patients considering participation, but mobile vision clinics are providing a solution to improve accessibility, capacity, and patient enrollment.
-
IRT: A New Approach To Meeting The Needs Of Early Phase Trials8/14/2025
As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
-
Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.
-
With over 13,000 drives completed and 10 driving simulators on-site, Altasciences is the ideal full-service provider for your driving simulator clinical trials.
-
Explore how integrated regulatory, statistical, and operational expertise can be applied to help sponsors navigate complex development pathways and accelerate global approvals.
-
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.